CLO25-061: 7-Gene Biosignature Reclassified Women With DCIS Meeting NCCN Guideline (RTOG 9804-Like) Low-Risk Criteria as Molecular High Risk
"CLO25-061: 7-Gene Biosignature Reclassified Women With DCIS Meeting NCCN Guideline (RTOG 9804-Like) Low-Risk Criteria as Molecular High Risk" published on 28 Mar 2025 by National Comprehensive Cancer Network.
Authors
- Chirag Shah (ORCID: https://orcid.org/0000-0002-9657-4767)
- Pat W. Whitworth (ORCID: https://orcid.org/0000-0002-6654-9990)
- Rachel Rabinovitch (ORCID: https://orcid.org/0000-0002-6016-2226)
- Eileen P. Connolly (ORCID: https://orcid.org/0000-0001-6558-1932)
- Troy M. Bremer (ORCID: https://orcid.org/0000-0001-6100-605X)
- Brian J. Czerniecki (ORCID: https://orcid.org/0000-0003-4519-9570)
- Steven C. Shivers (ORCID: https://orcid.org/0000-0001-9538-4016)
- Karuna Mittal
- G. Bruce Mann (ORCID: https://orcid.org/0000-0002-2508-9203)
- Frank A. Vicini
Institutions
- Cleveland Clinic (US)
- The University of Melbourne (AU)
- Columbia University Irving Medical Center (US)
- Moffitt Cancer Center (US)
- University of Colorado Cancer Center (US)
- Michigan Healthcare Professionals (US)
- PreludeDx (United States) (US)
- University of Colorado Denver (US)
Publication Details
- Journal
- Journal of the National Comprehensive Cancer Network
- Published
- 2025-03-28
- DOI
- https://doi.org/10.6004/jnccn.2024.7170
- Citations
- 1
- Primary Topic
- Biomedical Ethics and Regulation
- Type
- article
- Field-Weighted Citation Impact
- 1.16